Correlating the rs37389 Variant with Lipid Metabolism in Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus (T2DM) is increasingly recognized as a multifaceted metabolic disorder with significant genetic underpinnings, especially concerning lipid metabolism abnormalities such as dyslipidemia. This thesis investigates the correlation between the rs37389 variant, a single nucleotide polymorphism (SNP) within a crucial gene for lipid transport and metabolism, and lipid metabolism parameters in T2DM patients. Through a comprehensive study involving T2DM patients and healthy controls, we assessed the frequencies of the rs37389 genotypes (GG, AA, AG) and their associations with various metabolic parameters including Body Mass Index (BMI), lipid profiles (Total Cholesterol, Triglycerides, HDL, LDL, VLDL), and glycemic control indicators (HbA1C, Fasting Blood Sugar). Our findings reveal nuanced insights into the metabolic implications of the rs37389 variant in the T2DM context. While the observed trends in metabolic parameters across different rs37389 genotypes suggest potential genetic influences on lipid metabolism in T2DM, statistical significance was not achieved, pointing to the complexity of genetic impacts on metabolic traits in T2DM. The study underscores the importance of considering genetic factors alongside traditional risk factors in understanding and managing T2DM, particularly its dyslipidemic complications. Despite the limitations such as sample size and potential confounding variables, this thesis contributes to the growing body of research on the genetic basis of T2DM and highlights the need for further studies with larger cohorts and more controlled conditions to fully elucidate the role of the rs37389 variant in T2DM pathology.